Introduction to AI & ML techniques in Drug Discovery

Explore the ABCs of artificial intelligence and machine learning terminology, from algorithms and neural networks to deep learning, data science, and natural language processing.

Explore three main machine learning types: supervised, unsupervised, and reinforcement learning, and their applications in drug discovery and healthcare, including classification, regression, clustering, and feature discovery.

Learn the seven types of artificial intelligence, from narrow to superintelligent, and how type two functionalities, reactive, limited memory, theory of mind, and self-aware, enhance drug discovery with robotic screening.

Explore artificial neural networks and their applications in drug discovery, highlighting simple and multi-layer networks, convolution neural networks for image processing, and natural language processing for literature and patents.

The lecture introduces natural language processing and its drug discovery applications, detailing syntactic and semantic analysis and uses in literature mining and electronic health records.

Explore how artificial intelligence can accelerate drug discovery and reveal new targets. Assess drawbacks like data quality, algorithm bias, high compute costs, and the need for human validation.

Explore how ai and ml transform drug discovery by aggregating literature, deciphering mechanisms from sequencing data, and generating novel drug candidates through predictive modeling and target profiling.

Discover how artificial intelligence based information aggregation from vast literature uses semantic search, natural language processing, and clustering to organize open access papers into insights for drug discovery.

Explore how artificial intelligence and machine learning accelerate peer review in drug discovery by using UNSILO, Penelope, Statcheck, and Statreviewer to assess claims, formatting, and statistics.

Explore how AI and ML generate first drafts, auto-cite sources, and assemble methods and notes from papers, with limits on discussion content in drug discovery.

Explore how artificial intelligence and machine learning enable disease modeling, linking diseases and potential side effects via proprietary knowledge to inform drug discovery and repurposing.

Learn how artificial intelligence and machine learning reshape drug discovery. Apply neural networks and deep learning to target identification, validation, and lead optimization, predicting protein–ligand binding and toxicity.